Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Acute graft versus host disease


Other Names for this Disease
  • Acute GVHD
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

News & Events


ORDR Co-Sponsored Conferences

  • 2016 Rare Disease Day at NIH, Monday, February 29, 2016
    Location: Building 10, Masur Auditorium, National Institutes of Health, Bethesda, MD
    Description: The 2016 Rare Disease Day at NIH will take place on February 29. The event, sponsored by NCATS and the NIH Clinical Center, aims to raise awareness about rare diseases, the patients they affect and the research collaborations that are addressing rare disease challenges. The day will feature tours, posters and exhibits, and presentations.

  • Outcomes Database in Hematopoietic Cell Transplantation and Cellular Therapy for Autoimmune Diseases, Friday, April 19, 2013 - Saturday, April 20, 2013
    Location: Froedtert and Medical College of Wisconsin, Milwaukee, WI
    Description: The aim of this NIH workshop is to break the stalemate and facilitate interdisciplinary collaboration by creating functional clinical research teams on the national level who can then create a momentum for progress in this area of substantial unmet need and high promise. The CIBMTR infrastructure, which is currently cancer-focused, can be easily adapted to collect AID-specific data

  • Workshop on Clinical Trial Endpoints for Acute Graft-versus-Host Disease (Acute GVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT), and the Identification of Future Scientific Directions Needed to the Prevention of Acute GVHD, Tuesday, May 19, 2009 - Wednesday, May 20, 2009
    Location: Bethesda, MD
    Description: The primary focus was on validated endpoints that are ready for incorporation into clinical trials now or in the near future and on methods to address confounding issues unique to studies of acute GVHD. These will be used by the NHLBI-sponsored Blood and Marrow Transplant Clinical Trials Network (BMT CTN), and the materials will be made available publicly so that the endpoints may also be used by the oncology cooperative groups and corporate sponsors.

Other Names for this Disease
  • Acute GVHD
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.